Display options
Cite
Lutrick K, Groom H, Fowlkes AL, et al. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2021;40(3):494-502doi: 10.1016/j.vaccine.2021.11.094.
Lutrick, K., Groom, H., Fowlkes, A. L., Groover, K. D., Gaglani, M., Rivers, P., Naleway, A. L., Nguyen, K., Herring, M., Dunnigan, K., Phillips, A., Parker, J., Mayo Lamberte, J., Prather, K., Thiese, M. S., Baccam, Z., Tyner, H., & Yoon, S. (2022). COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine, 40(3), 494-502. https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick, Karen, et al. "COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers." Vaccine vol. 40,3 (2022): 494-502. doi: https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2022 Jan 24;40(3):494-502. doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11. PMID: 34906392; PMCID: PMC8665770.
Copy Download .nbib Format: NLM
Share it on

Vaccine. 2022 Jan 24;40(3):494-502. doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11.

COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.

Vaccine

Karen Lutrick, Holly Groom, Ashley L Fowlkes, Kimberly D Groover, Manjusha Gaglani, Patrick Rivers, Allison L Naleway, Kimberly Nguyen, Meghan Herring, Kayan Dunnigan, Andrew Phillips, Joel Parker, Julie Mayo Lamberte, Khaila Prather, Matthew S Thiese, Zoe Baccam, Harmony Tyner, Sarang Yoon

Affiliations

  1. Family & Community Medicine, College of Medicine - Tucson, University of Arizona, Tucson, AZ, 655 N Alvernon Way, Suite 228, Tucson, AZ, 85721, United States. Electronic address: [email protected].
  2. Center for Health Research, Kaiser Permanente Northwest, Portland, OR, United States. Electronic address: [email protected].
  3. Epidemiology Prevention Branch, Influenza Division, Centers of Disease Control and Prevention, Atlanta, GA, United States. Electronic address: [email protected].
  4. Abt Associates, Atlanta, GA, United States. Electronic address: [email protected].
  5. Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, TX, United States. Electronic address: [email protected].
  6. Family & Community Medicine, College of Medicine - Tucson, University of Arizona, Tucson, AZ, United States. Electronic address: [email protected].
  7. Center for Health Research, Kaiser Permanente Northwest, Portland, OR, United States. Electronic address: [email protected].
  8. Assessment Branch, Immunization Services Division, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: [email protected].
  9. Abt Associates, Atlanta, GA, United States. Electronic address: [email protected].
  10. Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, TX, United States. Electronic address: [email protected].
  11. Occupational and Environmental Health, School of Medicine, University of Utah, Salt Lake City, UT, United States. Electronic address: [email protected].
  12. Epidemiology and Biostatistics, College of Public Health, University of Arizona, Tucson, AZ, United States. Electronic address: [email protected].
  13. Epidemiology Prevention Branch, Influenza Division, Centers of Disease Control and Prevention, Atlanta, GA, United States. Electronic address: [email protected].
  14. Abt Associates, Atlanta, GA, United States. Electronic address: [email protected].
  15. Epidemiology and Biostatistics, College of Public Health, University of Arizona, Tucson, AZ, United States. Electronic address: [email protected].
  16. St. Luke's Infectious Disease Associates, St. Luke's Hospital, Duluth, MN, United States. Electronic address: [email protected].
  17. Occupational and Environmental Health, School of Medicine, University of Utah, Salt Lake City, UT, United States. Electronic address: [email protected].
  18. St. Luke's Infectious Disease Associates, St. Luke's Hospital, Duluth, MN, United States. Electronic address: [email protected].

PMID: 34906392 PMCID: PMC8665770 DOI: 10.1016/j.vaccine.2021.11.094

Abstract

INTRODUCTION: In a multi-center prospective cohort of essential workers, we assessed knowledge, attitudes, and practices (KAP) by vaccine intention, prior SARS-CoV-2 positivity, and occupation, and their impact on vaccine uptake over time.

METHODS: Initiated in July 2020, the HEROES-RECOVER cohort provided socio-demographics and COVID-19 vaccination data. Using two follow-up surveys approximately three months apart, COVID-19 vaccine KAP, intention, and receipt was collected; the first survey categorized participants as reluctant, reachable, or endorser.

RESULTS: A total of 4,803 participants were included in the analysis. Most (70%) were vaccine endorsers, 16% were reachable, and 14% were reluctant. By May 2021, 77% had received at least one vaccine dose. KAP responses strongly predicted vaccine uptake, particularly positive attitudes about safety (aOR = 5.46, 95% CI: 1.4-20.8) and effectiveness (aOR = 5.0, 95% CI: 1.3-19.1). Participants' with prior SARS-CoV-2 infection were 22% less likely to believe the COVID-19 vaccine was effective compared with uninfected participants (aOR 0.78, 95% CI: 0.64-0.96). This was even more pronounced in first responders compared with other occupations, with first responders 42% less likely to believe in COVID-19 vaccine effectiveness (aOR = 0.58, 95% CI 0.40-0.84). Between administrations of the two surveys, 25% of reluctant, 56% reachable, and 83% of endorser groups received the COVID-19 vaccine. The reachable group had large increases in positive responses for questions about vaccine safety (10% of vaccinated, 34% of unvaccinated), and vaccine effectiveness (12% of vaccinated, 27% of unvaccinated).

DISCUSSION: Our study demonstrates attitudes associated with COVID-19 vaccine uptake and a positive shift in attitudes over time. First responders, despite potential high exposure to SARS-CoV-2, and participants with a history of SARS-CoV-2 infection were more vaccine reluctant.

CONCLUSIONS: Perceptions of the COVID-19 vaccine can shift over time. Targeting messages about the vaccine's safety and effectiveness in reducing SARS-CoV-2 virus infection and illness severity may increase vaccine uptake for reluctant and reachable participants.

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this pa

References

  1. JMIR Res Protoc. 2021 May 26;: - PubMed
  2. Vaccines (Basel). 2020 Oct 03;8(4): - PubMed
  3. MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1857-1859 - PubMed
  4. Clin Infect Dis. 2021 Jul 22;: - PubMed
  5. JMIR Res Protoc. 2021 Dec 3;10(12):e31574 - PubMed
  6. MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):217-222 - PubMed
  7. Front Psychol. 2020 Oct 19;11:575950 - PubMed
  8. J Occup Environ Med. 2021 May 1;63(5):369-373 - PubMed
  9. J Community Health. 2021 Dec;46(6):1244-1251 - PubMed
  10. Int J Clin Pract. 2021 Apr;75(4):e13891 - PubMed
  11. N Engl J Med. 2021 Apr 8;384(14):1372-1374 - PubMed
  12. JAMA Netw Open. 2020 May 1;3(5):e209687 - PubMed
  13. N Engl J Med. 2021 Feb 18;384(7):e23 - PubMed
  14. Vaccine. 2021 Feb 12;39(7):1080-1086 - PubMed
  15. Prev Med. 2021 Dec;153:106833 - PubMed
  16. JAMA Netw Open. 2021 Mar 1;4(3):e215344 - PubMed
  17. Lancet Public Health. 2020 Sep;5(9):e475-e483 - PubMed

Publication Types